Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.

Autor:	Nassar GM; Houston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.; Weill Cornell - Medical College - Department of Internal Medicine, New York, NY, USA.; Panoramic Health, a Management Service Organization, Tempe, Arizona, USA., Jameson R; Houston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.; Weill Cornell - Medical College - Department of Internal Medicine, New York, NY, USA., Sathiyaraj S; Houston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.; Weill Cornell - Medical College - Department of Internal Medicine, New York, NY, USA., Bidikian N; American University of Beirut - Department of Internal Medicine, Beirut, Lebanon.; Harvard Medical School - Department of Internal Medicine, Boston, MA, USA., Villasmil Hernandez N; Houston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.; Weill Cornell - Medical College - Department of Internal Medicine, New York, NY, USA., Sahay S; Houston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.; Weill Cornell - Medical College - Department of Internal Medicine, New York, NY, USA.
Jazyk:	angličtina
Zdroj:	Clinical kidney journal [Clin Kidney J] 2024 Feb 28; Vol. 17 (4), pp. sfae047. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
DOI:	10.1093/ckj/sfae047
Abstrakt:	The occurrence of renal failure in pulmonary hypertension (PH) is an ominous sign and implies excessive adverse hemodynamic factors. Pharmacologic agents to treat the PH are the mainstay of management, whereas diuretics assist in management of fluid overload. However, when such measures fail, dialysis and ultrafiltration (UF) become necessary to manage progressive azotemia and hypervolemia. Reversal of PH is essential to interrupt this vicious cycle of multisystem failure; otherwise, the need for renal replacement therapy would be permanent. Competing Interests: None declared. (© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.)
Databáze:	MEDLINE
Externí odkaz: